Medicinal Products

Dáil Éireann Debate, Monday - 9 September 2024

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Monday, 9 September 2024

Questions (1597)

Paul McAuliffe

Question:

1597. Deputy Paul McAuliffe asked the Minister for Health the progress that has been made by the HSE in assessing ravulizumab for treatment of paroxysmal nocturnal haemoglobinuria and atypical haemolytic uremic syndrome; and if he will make a statement on the matter. [33912/24]

Written answers

Minister for Health

As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

• Previous Answer
• Next Answer